Grupo Cibest S.A. · CIB · FY2025 Q1 · Calendar Q2 2025

Grupo Cibest: resilient Q1 performance, with macro and integration risks

The available analysis supports a constructive but qualified view: resilient operating performance, digital-banking expansion, and deposit growth provide support, while macro uncertainty, integration execution, and credit-cost sensitivity could limit durability.

Reported Before market openNYSEFinancial Services $22.50B market cap
70quality score

Earnings scorecard

Reported versus consensus
Reported EPS — Consensus $1.62
EPS surprise — Reported versus consensus
Reported revenue — Consensus $7009.96B
Revenue surprise — Reported versus consensus

Market reaction

prior-close to event-session close
Stock move +1.1% Event window
SPY move +0.7% Same window
Abnormal move +0.4% Stock minus SPY
Volume 0.7× Versus trailing sessions
Subsequent drift +4.6% Up to 20 sessions
CIBSPY benchmark

Ask FN2 about CIB FY2025 Q1

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

The quarter's analysis emphasized the Nequi and A la Mano integration, the Grupo Cibest holding structure, digital expansion, and planned shareholder-return actions. Guidance was characterized as maintained rather than materially raised.

Guidance delta

Management guidance was described as maintained, including the full-year net interest margin outlook and cost-of-risk range.

Key takeaways

  • Management described a strong quarter with higher net income and return on equity.
  • The Nequi and A la Mano integration is a central growth initiative, alongside digital adoption and deposit gains.
  • Macro risks include inflation, fiscal pressure, political uncertainty, and potentially slower consumer-loan growth.
  • Capital ratios were presented as supporting shareholder distributions and planned capital actions.

Management priorities

  • Complete the Nequi and A la Mano integration
  • Scale digital banking, deposits, and lending
  • Deliver cost efficiency and digital-product rollout
  • Maintain capital flexibility while pursuing shareholder distributions

Follow CIB with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
CIB EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 4 future estimate-only quarters. Q1 '24 estimate $1.47 Q1 '24 actual $1.80, beat Q2 '24 estimate $1.43 Q2 '24 actual $1.44, match Q3 '24 estimate $1.45 Q3 '24 actual $1.49, beat Q2 '25 estimate $7,010.12 Q2 '25 actual $1.79, miss Q3 '25 estimate $1.81 Q3 '25 actual $2.18, beat Q4 '25 estimate $2.04 Q4 '25 actual $1.77, miss Q1 '26 estimate $1.84 Q1 '26 actual $1.62, miss Q2 '26 estimate $2.14 Q2 '26 actual $3.32, beat Q3 '26 estimate $2.87 Q4 '26 estimate $9,918.36 Q1 '27 estimate $10,579.66 Q2 '27 estimate $10,917.92
Show 1 more >

Analyst Consensus ?

ConsensusHold15 ratings
Bullish746.7%
Neutral533.3%
Bearish320.0%

Analyst 52W Price Targets

$94.81Current
$34Low
$77.4Average
$110High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 11, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
JP Morgan Neutral OverweightDowngradeSep 16, 2026
Goldman Sachs Buy BuyMaintainAug 13, 2026
B of A Securities Neutral UnderperformUpgradeJun 1, 2026
UBS Neutral NeutralMaintainApr 23, 2026
Itau BBA Underperform Market PerformDowngradeFeb 26, 2026
Citigroup Neutral BuyDowngradeJan 22, 2026
Morgan Stanley Overweight Equal WeightUpgradeJan 28, 2025
Credit Suisse Outperform NeutralUpgradeAug 2, 2022
HSBC Buy HoldUpgradeFeb 26, 2020
Santander Underperform HoldDowngradeNov 19, 2018
Standpoint Research Accumulate HoldUpgradeMar 7, 2018
Deutsche Bank Buy HoldUpgradeAug 22, 2016
Barclays Underweight UnderweightMaintainMar 24, 2016
Bank of America Neutral BuyDowngradeMar 14, 2016
BTG Pactual Buy BuyMaintainFeb 4, 2014
Show less

Named analyst price targets

Upside is calculated against the persisted current price $94.81. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Goldman SachsAnalyst unavailable$110$95.79 +16.0%Aug 13, 2026
RBC CapitalAnalyst unavailable$110$91.47 +16.0%Aug 11, 2026
Goldman SachsAnalyst unavailable$98$87.93 +3.4%Jul 28, 2026
UBSAnalyst unavailable$72$73.65 -24.1%Apr 23, 2026
Goldman SachsAnalyst unavailable$69$70.92 -27.2%Jan 13, 2026
Banco SantanderAndres Soto$61$61.83 -35.7%Dec 17, 2025
Bank of America SecuritiesErnesto Gabilondo$34$33.12 -64.1%Aug 29, 2024
Show less

Track every rating change on CIB the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Grupo Cibest SA functions as an investment holding enterprise, with its headquarters situated in Medellin, Colombia.

Historical context

All CIB earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the CIB recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2025-04-24T00:01:17.206701+00:00
  3. Polygon adjusted daily market bars · 2026-10-11T13:50:46.929535+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-11T13:50:46.926767+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-11. For educational purposes only; not investment advice.